Filling the need for trusted information on national health issues…

Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Innovative Partnerships Will Help End Extreme Poverty

Devex: Ending extreme poverty with a new model of development Rajiv Shah, USAID administrator “…For the first time in history, we stand within reach of a world that was simply once unimaginable: a world without extreme poverty. … The Busan High-Level Forum on Aid Effectiveness has built a strong foundation…

Public Health Advocates Seek Lower Prices For Hepatitis C Treatments

Nature: Hepatitis C drugs not reaching poor “…Three decades after wrestling to lower the cost of AIDS drugs (prices fell from about US$10,000 per patient per year in the 1990s to less than $100 in the mid-2000s), [public health researchers] are once again asking how expensive life-saving medicines can be…

Campaigners Remain Skeptical Over Nestlé’s Infant Formula Marketing Policy

The Guardian: Campaigners remain unpersuaded by Nestlé’s baby milk marketing policy Oliver Balch, freelance writer specializing in the role of business in society “… The Swiss firm [Nestlé] certainly espouses the ‘numerous benefits’ of breast milk and provide tips on breastfeeding. Yet its official infant formula policy falls short of…

Cooperation, Partnership Essential To Achieving Post-2015 Goals

José Cuesta, a development economist with the World Bank, writes in the agency’s blog about the post-2015 development goals. “The World Bank Group has explicitly stated that our new goals of eradicating extreme poverty and boosting shared prosperity cannot be achieved without institutions, structures, and processes that empower local communities,…

Sanofi Expects Dengue Vaccine Clinical Trial Results In September

Reuters: Sanofi faces make-or-break verdict on big dengue vaccine bet “Sanofi expects final clinical results for its vaccine against dengue by late September, the French drugmaker’s project leader has told Reuters, and has already gambled on starting production despite some disappointing early trials data. Sanofi has invested more than one…

Myanmar Remains Potential ‘Gateway’ for Spread Of Drug-Resistant Malaria, Experts Warn

IRIN: Curbing Myanmar’s spread of drug-resistant malaria “Efforts to halt the spread of drug-resistant malaria in Myanmar have delivered encouraging results through the private health sector, but health experts warn the [fight against the] disease cannot be won outside the public health system — and that the country is still…

Drugmaker GlaxoSmithKline To Invest $216M In Factories, R&D In Africa

Reuters: Drugmaker GSK to invest $200 million in African factories, R&D “Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent’s swelling urban middle classes…” (Hirschler, 3/31).

Deutsche Welle Discusses Balance Between For-Profit Drug Companies And Public Health Needs

Zulfikar Abbany of Deutsche Welle interviews Adrian Hill of the Jenner Institute on the issues and challenges involved in balancing the needs of for-profit pharmaceutical companies with public health goals. Deutsche Welle: Is profit more important than public health? In this audio episode of Spectrum, Zulfikar Abbany of Deutsche Welle…

‘Development Impact Bonds’ Can Drive Malaria Control Programs Forward

The Guardian: Malaria in Mozambique: trialing payment by results Lily Han, investment principal with Dalberg Global Development Advisers, a private sector partner working to launch the Mozambique Malaria performance bond “Malaria control programs in recent decades offer overwhelming evidence that integrated, sustained malaria-eradication protocols that cover prevention, diagnosis, and treatment…

GSK To Add Antiretroviral Drug To Medicines Patent Pool

Reuters: GSK’s ViiV unit adds new HIV drug to AIDS patent pool “GlaxoSmithKline’s AIDS drugs business is to add one of its latest HIV medicines to a patent pool — cutting its future price for developing countries and pooling intellectual property rights. ViiV Healthcare, which is majority owned by the…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.